Clinical Trials Directory

Trials / Unknown

UnknownNCT05069675

Cystoid Macular Edema After Vitrectomy for Rhegmatogenous Retinal Detachment

Incidence and Risk Factors for Cystoid Macular Edema After Primary Vitrectomy With Gas Tamponade for Rhegmatogenous Retinal Detachment: a National Study Group

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
University of Catania · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To investigate the incidence of cystoid macular edema in eyes with primary rhegmatogenous retinal detachment successfully treated with vitrectomy with gas tamponade, and to evaluate the clinical variables associated with its development.

Detailed description

this is an observational, retrospective, multicentre study. The study is based on the retrospective collection of clinical data from patients undergoing gas tamponade vitrectomy for rhegmatogenous retinal detachment. The collection of such data by the investigators will take place at each participating center anonymously. demographics, systemic, and preoperative, intraoperative and post-operative data will be collected The sample size was calculated to obtain approximately 200 patients with cystoid macular edema. Since cystoid macular edema has been detected in 13% of patients after retinal detachment gas vitrectomy, and assuming that this event can occur between 10% and 15% of cases, the study will include at least 2000 cases.

Conditions

Interventions

TypeNameDescription
PROCEDUREvitrectomyvitrectomy with gas tamponade

Timeline

Start date
2021-07-12
Primary completion
2022-10-01
Completion
2023-01-01
First posted
2021-10-06
Last updated
2022-05-25

Locations

6 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT05069675. Inclusion in this directory is not an endorsement.